REG - James Halstead PLC - Director/PDMR Shareholding

James HalsteadAnnouncement

Yesterday 12:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251114:nRSN6338Ha&default-theme=true

RNS Number : 6338H  James Halstead PLC  14 November 2025

14 November 2025

 

James Halstead plc

("James Halstead" or the "Company")

 

PDMR Acquisition of Shares

 

James Halstead plc (AIM: JHD) announces that on 14 November 2025, (1) Gordon
Richard Oliver, an Executive Director, Chief Executive and PDMR of the
Company, informed the Company that on the 14 November 2025, (2) Susan
Podesta-Oliver (PCA to Gordon Richard Oliver) had purchased 8,500 ordinary
shares of 5p each.

Following the above transaction, Gordon Richard Oliver's total beneficial
interest in the Company is 472,270 Ordinary Shares of 5p each, representing
approximately 0.11% of the Company's issued share capital.

The notification set out below, made in accordance with the requirements of
the EU Market Abuse Regulations, provides further detail.

  1    Details of the person discharging managerial responsibilities / person closely
       associated
 a)    Name                                                         (1)  Mr Gordon Richard Oliver

                                                                    (2)  Mrs Susan Podesta-Oliver
 2     Reason for the notification
 a)    Position/status                                              (1)   Executive Director and Chief Executive

                                                                    (2)   PCA to Gordon Richard Oliver
 b)    Initial notification /Amendment                              Initial Notification

 3     Details of the issuer, emission allowance market participant, auction

     platform, auctioneer or auction monitor

 a)    Name                                                         James Halstead plc
 b)    LEI                                                          213800C8FFBYVO6UL498
 4     Details of the transaction(s): section to be repeated for (i) each type of

     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the financial instrument, type of instrument  Ordinary Shares of 5p each

       Identification code

                                                                    GB00B0LS8535

 b)    Nature of the transaction                                    Purchase of 8,500 ordinary shares of 5p each by Susan Podesta-Oliver

 c)    Price(s) and volume(s)                                        Prices per share   Volume(s)

                                                            1. £1.3551          8,500

 d)    Aggregated information

                                                             8,500
       - Aggregated volume

                                                             £1.3551
       - Price
 e)    Date of the transaction                                      14 November 2025

 f)    Place of the transaction                                     London Stock Exchange - AIM

 

d)

Aggregated information

- Aggregated volume

- Price

  8,500

  £1.3551

 

e)

Date of the transaction

14 November 2025

 

 

f)

Place of the transaction

London Stock Exchange - AIM

 

 

Name of authorised official of issuer responsible for making notification:

David Fletcher, Company Secretary to James Halstead plc

 For further information please contact:
 James Halstead plc:

David Fletcher, Company Secretary

                                                          Telephone 0161 767 2500

 Hudson Sandler:

 Nick Lyon / Nick Moore                                   Telephone: 020 7796 4133

 Panmure Liberum (Nominated adviser & Joint broker):

 Edd Mansfield / Tom Scrivens                             Telephone: 020 7886 2500

 Zeus (Joint Broker):

 Ben Thorne / Fraser Marshall                             Telephone: 020 3829 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFSLLDLSLIE



            Copyright 2019 Regulatory News Service, all rights reserved